| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/02/2001 | US20010010928 Protozoan expression system |
| 08/02/2001 | US20010010926 New immunoregulatory protein lst-1 |
| 08/02/2001 | US20010010925 Medical diagnosis/screening, inflammation; extracellular signal molecules; antitumor and antimetastasis agents |
| 08/02/2001 | US20010010924 Inflammation, arthritis, septicemia, brain injury, autoimmune (inflammatory bowel, psoriasis)/bone/acute respiratory diseases, restenosis, AIDS, cancer (lympho-proliferative disorders, atheroscleosis, and Alzheimer's |
| 08/02/2001 | US20010010922 Degrading B-cell lymphomas in cells using phosphorylation inductors such as mitogen-activated protein kinase, antibodies, anti-immunoglobulins antibodies; treatment of (non-Hodgkin's) lymphoma |
| 08/02/2001 | US20010010921 Cell-free and cell-based assays for screening drugs to treat eating disorders; dietetics; obesity, cachexia |
| 08/02/2001 | US20010010919 Opioid antagonists and methods of their use |
| 08/02/2001 | US20010010913 Isolated polypeptide |
| 08/02/2001 | US20010010912 nrdF |
| 08/02/2001 | US20010010908 Reagents and methods useful for detecting diseases of the prostate |
| 08/02/2001 | US20010010901 Genetic engineering |
| 08/02/2001 | US20010010899 Genetic engineering |
| 08/02/2001 | US20010010821 For treatment of gastrointestinal disorders |
| 08/02/2001 | US20010010820 Delaying onset of insulin dependent diabetes mellitus by administering immunologically active monoclonal antibody against glutamic acid decarboxylase coupled to a nonimmunogenic polymer that provides shell around antibody |
| 08/02/2001 | US20010010819 Septicemia |
| 08/02/2001 | US20010010815 Adeno-associated vector compositions for expression of factor VIII |
| 08/02/2001 | EP1144440A3 Neurotransmitter transporter |
| 08/02/2001 | DE19955349A1 Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen Use of polypeptides or nucleic acids encoding them for the diagnosis or treatment of skin disorders and their use for the identification of pharmacologically active substances |
| 08/02/2001 | DE10001377A1 bHLH-Transkriptionsfaktor ASCL3 und diesen enthaltendes Arzneimittel bHLH transcription factor AsCl3 and this medicinal product containing |
| 08/02/2001 | CA2401086A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases |
| 08/02/2001 | CA2398821A1 Composition for treatment of stress |
| 08/02/2001 | CA2398792A1 Auxiliary medicament for ophthalmic operation |
| 08/02/2001 | CA2398791A1 Human membrane proteins and polynucleotides encoding the same |
| 08/02/2001 | CA2398788A1 Slow release protein polymers |
| 08/02/2001 | CA2398743A1 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
| 08/02/2001 | CA2398660A1 Human cyr61 |
| 08/02/2001 | CA2398631A1 Slimming cosmetic composition comprising as an ative agent a plant extract containing a plant natriuretic peptide (pnp) |
| 08/02/2001 | CA2398564A1 Nuclear hormone receptors |
| 08/02/2001 | CA2398563A1 Modulation of gene expression in formation of fatty atherosclerotic lesions |
| 08/02/2001 | CA2398554A1 Novel nucleic acids and polypeptides |
| 08/02/2001 | CA2398548A1 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | CA2398546A1 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398521A1 Compositions and methods for inhibition of hiv-1 infection |
| 08/02/2001 | CA2398430A1 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | CA2398411A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2398396A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398310A1 Methods for treating kidney disorders with pax2 |
| 08/02/2001 | CA2398283A1 Peptide fragments of colostrinin and their use |
| 08/02/2001 | CA2398251A1 Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides |
| 08/02/2001 | CA2398242A1 Fil-1 theta dnas and polypeptides |
| 08/02/2001 | CA2398227A1 17 human secreted proteins |
| 08/02/2001 | CA2398199A1 Novel therapeutic agents that use a .beta.3 agonist |
| 08/02/2001 | CA2398139A1 Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha |
| 08/02/2001 | CA2398003A1 Phosphodiesterases |
| 08/02/2001 | CA2397998A1 Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infection |
| 08/02/2001 | CA2397991A1 Diagnosis of tauopathies determining tau/phospho-tau ratio |
| 08/02/2001 | CA2397839A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2397680A1 Use of fsh for treating infertility |
| 08/02/2001 | CA2397643A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 08/02/2001 | CA2397407A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2397267A1 Peptide fragments and uses thereof as type-1 interferon antagonist |
| 08/02/2001 | CA2396920A1 Process for solubilizing glucagon-like peptide 1 (glp-1) compounds |
| 08/02/2001 | CA2396781A1 A method of administering a medicinal aerosol formulation |
| 08/02/2001 | CA2396719A1 22 human secreted proteins |
| 08/02/2001 | CA2396596A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method |
| 08/02/2001 | CA2395885A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395872A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395858A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395827A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395816A1 Nucleic acids, proteins and antibodies |
| 08/02/2001 | CA2395787A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395734A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395693A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395676A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395671A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395666A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395654A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395446A1 Compositions, kits, and methods for cardiovascular health |
| 08/02/2001 | CA2395403A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395398A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395295A1 Nucleic acids, proteins and antibodies |
| 08/02/2001 | CA2395178A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2394841A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2394039A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393941A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393912A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393652A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393618A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393616A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393002A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392757A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392751A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392438A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392428A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392422A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392398A1 Nucleic acids, proteins, and antibodies |
| 08/01/2001 | EP1120463A1 Apoptin-associating protein |
| 08/01/2001 | EP1119772A1 A novel ret-independent signaling pathway for gdnf |
| 08/01/2001 | EP1119643A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-$g(a) (TNF-$g(a)) EXPRESSION |
| 08/01/2001 | EP1119642A1 Compounds and methods for enhancing delivery of free polynucleotide |
| 08/01/2001 | EP1119629A2 Oxidoreductase molecules |
| 08/01/2001 | EP1119627A2 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 08/01/2001 | EP1119625A1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
| 08/01/2001 | EP1119622A2 Bax-mediated apoptosis modulating reagents and methods |
| 08/01/2001 | EP1119621A2 G-protein coupled receptor proteins |
| 08/01/2001 | EP1119620A2 Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses |
| 08/01/2001 | EP1119619A2 Nlk1 -interacting proteins |
| 08/01/2001 | EP1119618A2 Stress promoter control of therapeutic genes in gene therapy: compositions and methods |
| 08/01/2001 | EP1119615A1 PRODUCTION OF ssDNA IN VIVO |